Elisa Lledó

Elisa Lledó

Auto-generated profile, based on publicly available information

Elisa Lledó

Unidad de Cardiorregeneración, Centro de Investigación Príncipe Felipe, Valencia, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2007 in Stem Cells
Verified
Journal Article
Open access
PDF file
CGCarolina Gandia
Carolina Gandia
AAAna Armiñan
Ana Armiñan
JGJose Manuel García-Verdugo
Jose Manuel García-Verdugo
ELElisa Lledó
Elisa Lledó
ARAmparo Ruiz
Amparo Ruiz
Pilar SepúlvedaPilar Sepúlveda
Pilar Sepúlveda
Human dental pulp contains precursor cells termed dental pulp stem cells (DPSC) that show self-renewal and multilineage differentiation and also secrete multiple proangiogenic and antiapoptotic factors. To examine whether these cells could have therapeutic potential in the repair of myocardial infarction (MI), DPSC were infected with a retrovirus encoding the green fluorescent protein (GFP) and expanded ex vivo. Seven days after induction of myocardial infarction by coronary artery ligation, 1.5 × 106 GFP-DPSC were injected intramyocardially in nude rats. At 4 weeks, cell-treated animals showed an improvement in cardiac function, observed by percentage changes in anterior wall thickening left ventricular fractional area change, in parallel with a reduction in infarct size. No histologic evidence was seen of GFP+ endothelial cells, smooth muscle cells, or cardiac muscle cells within the infarct. However, angiogenesis was increased relative to control-treated animals. Taken together, these data suggest that DPSC could provide a novel alternative cell population for cardiac repair, at least in the setting of acute MI. Disclosure of potential conflicts of interest is found at the end of this article.

31 March 2012 in Stem Cell Reviews and Reports
Verified
Journal Article
Open access
PDF file
RCRubén Carrero
Rubén Carrero
ICInmaculada Cerrada
Inmaculada Cerrada
ELElisa Lledó
Elisa Lledó
JDJoaquin Dopazo
Joaquin Dopazo
FGFrancisco García García
Francisco García García
Pilar SepúlvedaPilar Sepúlveda
Pilar Sepúlveda
Mesenchymal stem cells are often transplanted into inflammatory environments where they are able to survive and modulate host immune responses through a poorly understood mechanism. In this paper we analyzed the responses of MSC to IL-1β: a representative inflammatory mediator. Microarray analysis of MSC treated with IL-1β revealed that this cytokine activateds a set of genes related to biological processes such as cell survival, cell migration, cell adhesion, chemokine production, induction of angiogenesis and modulation of the immune response. Further more detailed analysis by real-time PCR and functional assays revealed that IL-1β mainly increaseds the production of chemokines such as CCL5, CCL20, CXCL1, CXCL3, CXCL5, CXCL6, CXCL10, CXCL11 and CX3CL1, interleukins IL-6, IL-8, IL23A, IL32, Toll-like receptors TLR2, TLR4, CLDN1, metalloproteins MMP1 and MMP3, growth factors CSF2 and TNF-α, together with adhesion molecules ICAM1 and ICAM4. Functional analysis of MSC proliferation, migration and adhesion to extracellular matrix components revealed that IL-1β did not affect proliferation but also served to induce the secretion of trophic factors and adhesion to ECM components such as collagen and laminin. IL-1β treatment enhanced the ability of MSC to recruit monocytes and granulocytes in vitro. Blockade of NF-κβ transcription factor activation with IκB kinase beta (IKKβ) shRNA impaired MSC migration, adhesion and leucocyte recruitment, induced by IL-1β demonstrating that NF-κB pathway is an important downstream regulator of these responses. These findings are relevant to understanding the biological responses of MSC to inflammatory environments.

1 July 2009 in Stem Cells and Development
Verified
Journal Article
Closed access
AAAna Armiñán
Ana Armiñán
CGCarolina Gandía
Carolina Gandía
MBMa Carmen Bartual
Ma Carmen Bartual
JGJose Manuel García-Verdugo
Jose Manuel García-Verdugo
ELElisa Lledó
Elisa Lledó
Pilar SepúlvedaPilar Sepúlveda
Pilar Sepúlveda
Myocardial infarction is a major public health problem that causes significant mortality despite recent advances in its prevention and treatment. Therefore, approaches based on adult stem cells represent a promising alternative to conventional therapies for this life-threatening condition. Mesenchymal stem cells (MSCs) are self-renewing pluripotent cells that have been isolated from multiple tissues and differentiate to various cell types. Here we have analyzed the capacity of MSCs from human bone marrow (BMSC), adipose tissue (ATSC), and dental pulp (DPSC) to differentiate to cells with a cardiac phenotype. Differentiation of MSCs was induced by long-term co-culture with neonatal rat cardiomyocytes (CMs). Shortly after the establishment of MSC-CM co-cultures, expression of connexin 43 and the cardiac-specific markers troponin I, β-myosin heavy chain, atrial natriuretic peptide, and α-sarcomeric actinin was detected in BMSCs, ATSCs, and DPSCs. Expression of differentiation markers increased over time in the co-cultures, reaching the highest levels at 4 weeks. Translocation of the transcription factors NKX2.5 and GATA4 to the nucleus was observed in all three cultures of MSCs during the differentiation process; moreover, nuclear localization of NKX2.5 and GATA4 correlated with expression of α-sarcomeric actinin. These changes were accompanied by an increase in myofibril organization in the resulting CM-like cells as analyzed by electron microscopy. Thus, our results provide novel information regarding the differentiation of tissue-specific MSCs to cardiomyocytes and support the potential use of MSCs in cell-based cardiac therapies.

1 May 2010 in JACC
Verified
Journal Article
Closed access
AAAna Armiñán
Ana Armiñán
CGCarolina Gandía
Carolina Gandía
JGJose Manuel García-Verdugo
Jose Manuel García-Verdugo
ELElisa Lledó
Elisa Lledó
CTCésar Trigueros
César Trigueros
Pilar SepúlvedaPilar Sepúlveda
Pilar Sepúlveda

21 October 2009 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
AAAna Armiñán
Ana Armiñán
CGCarolina Gandía
Carolina Gandía
JGJose Manuel García-Verdugo
Jose Manuel García-Verdugo
ELElisa Lledó
Elisa Lledó
JMJosé Luis Mullor
José Luis Mullor
Pilar SepúlvedaPilar Sepúlveda
Pilar Sepúlveda